Woodley Farra Manion Portfolio Management’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
Other funds holding ABBV
VCM
VPM
Woodley Farra Manion Portfolio Management's ABBV Position: Q1 2026 in Review
Woodley Farra Manion Portfolio Management increased its AbbVie (ABBV) stake by 1.3% in Q1 2026, buying an estimated $68.1K and bringing the position to 23,506 shares worth $5.11M. The position accounts for 0.25% of the portfolio, ranked #49.
Woodley Farra Manion Portfolio Management first reported a position in ABBV in Q3 2013 and has held it in 28 quarters since. The position peaked at $5.3M in Q4 2025. 4,087 funds tracked by Wall St. Rank hold ABBV as of Q1 2026.
- Woodley Farra Manion Portfolio Management held 23,506 shares of AbbVie worth $5.11M as of Q1 2026.
- Woodley Farra Manion Portfolio Management bought 307 AbbVie shares in Q1 2026, an estimated $68.1K.
- AbbVie made up 0.25% of Woodley Farra Manion Portfolio Management's portfolio in Q1 2026, its #49 holding.
- Woodley Farra Manion Portfolio Management first reported a position in AbbVie in Q3 2013 and has held it in 28 quarters since.
- Woodley Farra Manion Portfolio Management's AbbVie position peaked at $5.3M in Q4 2025.
- 4,087 funds tracked by Wall St. Rank held AbbVie as of Q1 2026.
Based on Woodley Farra Manion Portfolio Management's 13F filing for Q1 2026, filed 8 May 2026.